Hemodynamic effects.
Conditions
Interventions
Intervention 1: Intervention group: 3.6 millilitre of the anaesthetic solution is drawn with insulin syringes from 10 millilitre vial of 0.5% ropivacaine made by Molteni Pharmaceutical Company. The i
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients who need to place 1 implant bilaterally in the posterior areas (premolar or molar) in one jaw Systemically healthy individuals (ASA I)
Exclusion criteria
Exclusion criteria: Patients with a history of allergy to local anesthetic agents, amides and sulfides Patients with acute or chronic infection near the surgical site Smokers Alcohol consumption Consumers of antipsychotic drugs, antidepressants and oral contraceptives People who have taken painkillers in the 48 hours before surgery People with a history of chronic facial pain Pregnant and lactating women Patients who need immediate implant placement (class1) Patients who need open / closed sinus lift surgery at the surgical site Patients who need bone augmentation (GBR) at the surgical site Patients who refuse to take part in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: Before the injection, immediately after the injection, 10 minutes after the injection, 20 minutes after the injection, 30 minutes after the injection, 1 hour after the injection. Method of measurement: Pulse Oximeter.;Systolic blood pressure. Timepoint: Before the injection, immediately after the injection, 10 minutes after the injection, 20 minutes after the injection, 30 minutes after the injection, 1 hour after the injection. Method of measurement: Wrist Blood Pressure Monitor.;Diastolic blood pressure. Timepoint: Before the injection, immediately after the injection, 10 minutes after the injection, 20 minutes after the injection, 30 minutes after the injection, 1 hour after the injection. Method of measurement: Wrist Blood Pressure Monitor.;Saturation of Peripheral Oxygen (SPo2). Timepoint: Before the injection, immediately after the injection, 10 minutes after the injection, 20 minutes after the injection, 30 minutes after the injection, 1 hour after the injection. Method of measurement: Pulse Oximeter.;Onset of anesthesia. Timepoint: From the time when the needle is pulled out of the tissue. Method of measurement: Stopwatch.;Duration of anesthesia. Timepoint: From the time when the needle is pulled out of the tissue until the anesthetic effect wears off. Method of measurement: Stopwatch.;The amount of pain felt during the injection. Timepoint: During the injection. Method of measurement: Visual Analogue Scale.;The amount of pain felt during the surgery. Timepoint: During the surgery. Method of measurement: Visual Analogue Scale.;Duration of analgesia after the surgery. Timepoint: From the time when the needle is pulled out of the tissue until the time of the onset of pain after the surgery. Method of measurement: Stopwatch.;Numbers of painkillers taken after the surgery. Timepoint: After the end of the surgery to 1 week. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNegar Daneshvar
Shahid Beheshti University of Medical Sciences
Outcome results
None listed